An official website of the United States government
PAR-18-559 - Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 4
Active NOSIs
| Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
|---|
Expired NOSIs
| Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Research in the Emergency Setting | NOT-NS-20-005 | NINDS NCI NIDA NHLBI NIDCD NIAAA NICHD NIA NIGMS NEI NIMHD NIMH | Sep 8, 2020 | Sep 8, 2022 | R01, R21, R03, K01, K99/R00, K08, K23, R13, R43/R44, R41/R42, P01, U01, R34, R35, RM1 |
| Notice of Special Interest (NOSI): Research on Oral Anticancer Agents in the Contexts of Utilization, Adherence, and Health Care Delivery | NOT-CA-20-026 | NCI | Feb 21, 2020 | May 8, 2023 | R01, R21, R03, P01 |
| Notice of Special Interest (NOSI): De-implementation of Ineffective or Low-value Clinical Practices along the Cancer Care Continuum | NOT-CA-20-021 | NCI | Jan 6, 2020 | May 10, 2022 | R01 |
| Notice of Special Interest: NCI's Research Interests to Improve Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment | NOT-CA-19-059 | NCI | Aug 8, 2019 | Jan 8, 2022 | R01, P01 |
